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The worldwide incidence of diabetes mellitus has reached alarming proportions. Persistent
hyperglycemia due to impaired insulin activity and/or insulin resistance inversely affects
the retina, cerebrovascular system, kidney, peripheral limbs, and other parts of the body,
which leads to life-threatening complications. The causal role of oxidative stress in the
development and progression of diabetic complications has been emphasized. Polyphenols
present in natural products have gained much attention in recent decades in preventive
studies against diabetes-associated pathologies. In the present review, we provide a com-
parative update on the role of quercetin, myricetin, and resveratrol—the major polyphenolsyperglycemia
xidative stress
olyphenols
present in red grapes—in intervening with diabetic complications, and a brief highlight on
the molecular mechanisms underlying oxidative stress mediated hyperglycemia.
© 2014 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access
of diet.. Introduction
iabetes mellitus is the most common metabolic disorder,
eing ranked as the fourth most common cause of mortal-
ty. According to the International Diabetes Federation, there
re approximately 366 million diabetic individuals around the
orld.1 The Federation assumes that this ﬁgure could increase
o 552 million by the year 2030.2
Diabetes mellitus is characterized by hyperglycemia due to
artial or absolute lack of insulin activity and/or insulin resis-
ance. Hyperglycemia-mediated oxidative stress and chronic
nﬂammatory components in diabetic tissues cause the accu-
ulation of advanced glycation end products (AGEs), lipid
eroxidation products, protein carbonyls, and late-stage gly-
oxidation adducts of proteins that results in toxicity in the
ardiovascular system, retina, kidney, peripheral limbs, and
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other parts of the body.3,4 These impairments play a major
role in the development of diabetic complications.5,6
Many factors have been implicated to play crucial role in
the development of hyperglycemia and progression of dia-
betes. Physical inactivity, sedentary lifestyle, ﬂawed dietary
attributes, being overweight, and obesity are some of the
factors directly associated with insulin resistance, followed
by state of impaired glucose metabolism, and eventually
diabetes.7,8 An evaluation of all the factors contributing to the
development of diabetes has been conducted, wherein obesity
and dietary attributes are considered major contributors.9,10 It
has been reported that glucose tolerance and insulin sensitiv-
ity may be modiﬁed by both the quantity as well as the quality
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defense mechanism for survival during adverse conditions
and to provide resistance against microbial infections.12,13
Based on the large quantity of data available through clin-
ical and epidemiological studies, polyphenols have received
considerable interest for their presumed role in the pre-
vention of various degenerative diseases.14–16 Antidiabetic
effect is one of the most intensely studied biological roles
of polyphenols.15,17 Grapes and their products, including red
wine, are largely consumed dietary components all over
the word. The observation of a lower incidence of coronary
heart disease despite a high-fat diet in the French popu-
lation, commonly referred to as the “French paradox”, has
also been attributed to a copious consumption of red wine
made from grapes. This has stimulated interest in investi-
gating whether grape polyphenols may offer consequential
health beneﬁts, including improved insulin sensitivity.18,19
The present review is a comparative study of the antidi-
abetic effects of quercetin, myricetin, and resveratrol, the
major polyphenols present in red grapes, incorporating a
brief account of the molecular mechanism involved in the
prevalence of hyperglycemia. The criteria for selection of
papers for the present study was adopted from the method
described by Siwek et al.20 The paper search was carried
out using online sources of evidence-based reviews databases
such as the Center for Research Support, TRIP Database
(http://www.tripdatabase.com/index.html), American College
of Physicians Journal Club (http://acpjc.acponline.org), and
Medline (http://www.ncbi.nlm.nih.gov/pubmed/).
2. Role of oxidative stress in
hyperglycemia-induced diabetic complications
Ample evidence exists showing that oxidative stress plays
a pivotal role in the development of diabetes and associ-
ated complications. Oxidative stress damages the vital cellular
molecules including proteins, lipids, and DNA, resulting in
functional loss and ultimately impaired cellular physiology.21
Studies have reported alterations in ion transporters, mem-
brane integrity, and redox imbalance in erythrocytes of
diabetic humans.6,21 Oxidative stress mediated insulin resis-
tance, dysfunctional pancreatic islets, and tissue damage lead
to late pathological consequences of diabetes.22,23 Because
pancreatic islets possess a low level of intrinsic antioxi-
dant enzymes such as superoxide dismutase, catalase, and
glutathione peroxidase, they remain at greater risk of dam-
age from reactive oxygen species (ROS).24,25 Laboratory and
clinical studies have radially reported that most of the mech-
anisms involved in the tissue damage and development of
diabetic complications during hyperglycemia are activated
by the overproduction of ROS in the cells.4,6 Receptors for
AGE binding have been reported to induce the production
of ROS, which in turn activates the pleotropic transcription
nuclear factor B, causing multiple pathological changes in
26gene expression. ROS have also been reported to inﬂuence
thepolyol pathwayandactivate protein kinasesC (PKC),which
serve as further pathways mediating tissue damage during
diabetes.6Integr Med Res ( 2 0 1 4 ) 119–125
2.1. Increased activity of the polyol pathway
The polyol pathway is a combination of aldo-ketoreductase
enzymes that reduce glucose and other carbonyl compounds
into respective sugar alcohols by using nicotinamide adenine
dinucleotide phosphate (NADPH). In this pathway, glucose is
ﬁrst converted into sorbitol through an NADPH-dependent
reaction by the enzyme aldose reductase and later oxidized
to fructose by sorbitol dehydrogenase.6 Normally, this path-
way contributes very little in the metabolism of glucose in
blood; however, during hyperglycemia the activity of this
system increases by many folds, resulting in excess con-
version of glucose into sorbitol, which leads to enhanced
consumption of NADPH. Excess consumption of NADPH leads
to depletion of the reduced glutathione (GSH) level because
NADPH is required to regenerate GSH. GSH, as a primary
scavenger of ROS, plays a very crucial role in maintaining
the cellular redox state. A diminished regeneration of GSH
adds burden to oxidative stress during diabetes.22,23 More-
over, decreased glutathiolation of cellular proteins has been
related to the reduced availability of nitric oxide that would
diminish S-nitrosoglutathione.6 Increasedpolyol pathwayﬂux
also leads to an increase in the cytosolic NADH/NAD+ ratio,
thereby inhibiting the activity of the enzyme glyceraldehyde-
3-phosphate dehydrogenase, which leads to an increase in
the concentration of triose phosphate. Elevated levels of
triose phosphate can increase the generation of methylgly-
oxal (precursor of AGEs) and diacylglycerol.23,27 Moreover,
the accumulation of sorbitol generates reciprocal depletion
of taurine. Taurine is an intracellular osmolyte and endoge-
nous antioxidant, the depletion of which may compromise
the antioxidative defense in many ways. Thus, the acti-
vated polyol pathway may contribute to the oxidative burden
through cofactor as well as osmotic mechanisms.28
2.2. Elevated AGEs and PKC
AGEs are generated by the nonenzymatic reaction of glucose
with proteins.27 AGEs and their precursors are highly reac-
tive; they interact with intracellular proteins as well as other
matrix compounds and alter their functions. In addition, AGE
receptors binding to endothelial cells appear to mediate, in
part, increased vascular permeability and impaired wound
healing.6,27
AGEs are found in almost all tissues examined in diabetic
rats and diabetic humans, but their susceptibility to AGE for-
mation differs.21 Cells of the liver, kidney, and erythrocytes
possess a higher susceptibility towards AGE formation. AGE-
modiﬁed proteins adversely affect many cellular processes
including cell adhesion and aggregation.29 AGEs appear to play
a central role in heart failure and increased mortality after
ischemic events in diabetic patients.21
PKCs are widely distributed in all mammalian tissues.
They phosphorylate many target proteins. The activity of
PKC depends on calcium ion, phosphatidyl serine, and
diacylglycerol.30 It has been suggested that interaction
between AGEs and cell surface receptors enhances the expres-
sion of PKC and their isoforms.31 Elevation in diacylglycerol
concentration due to increased polyol pathway ﬂux also
causes activation in PKC. The activation of PKC has a number
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f pathogenic consequences including abnormalities in blood
ow and permeability by affecting the expression of endothe-
ial nitric oxide synthase.6,32 The persistence of high glucose
evels induces fatty acid oxidation, which contributes to the
athogenesis of diabetic complications through increasing the
ux of fructose-6-phophate into the hexamine pathway.6,23
n the hexamine pathway, fructose-6-phosphate is used to
ynthesize uridine diphosphate-N-acetylglucosamine, which
s used by speciﬁc O-N-acetylglucosamine (GlcNAc) trans-
erases for posttranslational modiﬁcation of speciﬁc serine
nd threonine residues on cytoplasmic and nuclear pro-
eins by O-GlcNAcylation. Hyperglycemia-mediated increased
exosamine pathway ﬂux increases the O-GlcNAcylation of
he transcription factors and gene transcription, leading
o changes in both gene expression and protein function,
hich together contribute to the pathogenesis of diabetic
omplications.24,33
. Antidiabetic interventions and plant
olyphenols
large number of conventional drugs are used to man-
ge hyperglycemia; however, most of them fail to provide
ong-term control. Antidiabetic agents include sulfonylureas,
iguanides, metformin, glinides, and insulin, many of which
ave serious adverse side effects.34 The rising trend in the
revalence of diabetes and associated complications all over
he world suggests that existing medical treatments for
iabetic pathologies are not sufﬁcient and use of supplemen-
ary/complimentary treatments such as functional foods and
heir nutraceuticals may enhance the effectiveness of diabetic
anagement.35,36 Among the known bioactive compounds
nd phytochemicals, plant polyphenols have gained much
ttention and popularity because of their antihyperglycemic
ffects and minimal side/adverse effects.37 The reported ben-
ﬁcial health effects of polyphenols have led to an upsurge in
cientiﬁc interest in these natural compounds during the past
ecade. Many laboratory studies and clinical trials on animals
nd on humans have proposed plant polyphenols to be effec-
ive in a complimentary role for diabetes management.37,38
The antihyperglycemic effects of polyphenols have been
ttributed to many biological properties including reduction
n intestinal absorption of dietary carbohydrates, modulation
f the activities of enzymes involved in glucose metabolism,
rotection of  cell from oxidative injury, and stimula-
ion of insulin secretion and action.37,39 Other signiﬁcant
omplimentary roles of polyphenols have been observed
n the treatment of cardiovascular problems in diabetic
atients. Studies have revealed that the regulation of lipid
nd lipoprotein metabolism and improvement of dyslipi-
emia may be the factors behind the improvement of
ascular functions in diabetic patients receiving polyphenol
upplementation.40 Moreover, alleviation of oxidative stress
nd stress-sensitive pathways and inﬂammatory processes
ave also been reported that highlight the biological roles of
lant polyphenols, which establish their putative complimen-
ary role against diabetic complications.37 In the following
ections,we reviewevidence-based studies on the antidiabetic
ffects of quercetin, myricetin, and resveratrol.121
3.1. Quercetin
Quercetin (3,3′,4′,5,7-pentahydroxyﬂavone) is one of the most
studied polyphenolic compounds because of its pleotropic
biological properties including its anti-inﬂammatory, antiox-
idative, and neuroprotective activities.41,42 Belonging to the
ﬂavonoid group of polyphenols, quercetin contains three rings
and ﬁve hydroxyl groups in its structure (Fig. 1).
Many in vitro as well as in vivo studies have reported
the signiﬁcant protective potential of quercetin against dia-
betic complications.42,43 Supplementation of quercetin up to
10mg/kg body weight/day for 10 weeks improved the insulin
resistance in genetically obese Zucker rats.44 In another study,
Wistar rats on a high fructose diet supplemented with 25mg
quercetin/kg body weight/day were reported to show a higher
expression of adiponectin in white adipose tissue and blood
concentration, despite an inhibition of poly(ADP-ribose) poly-
merase  expression.45 It is concluded that the effect of
quercetin on adiponectin was poly(ADP-ribose) polymerase
-independent. Because adiponectin is an adipokine, which
facilitates insulin action, it is proposed that the increase
in adiponectin level might be a factor responsible for the
improvement in insulin sensitivity induced by quercetin.45
Recently, Kim et al46 reported a reduction in serum glucose
level and glycated hemoglobin in C57BL/KsJdb–db mice sup-
plemented with quercetin for 7 weeks. The study performed
by Coskun et al.47 on diabetic rats showed that quercetin
has the ability to protect streptozotocin-induced damage in
 cells and thereby normalize the serum glucose level. Like-
wise, Kobori et al48 reported that quercetin in the diet led
to the recovery of cell proliferation in streptozotocin-induced
diabetic mice. Quercetin in micromolar quantities has been
reported to protect lipid peroxidation in oxidatively stressed
humanerythrocytes obtained fromdiabetic individuals.More-
over, quercetin signiﬁcantly restored the depleted level of
cellular antioxidant molecules in diabetic cells during oxida-
tive stress.43
Different mechanisms have been reported by which
quercetin may elicit an antidiabetic effect. Glycemic control
achieved by quercetin has been attributed to the inhibition of
glucose uptake at the level of glucose transporters (GLUTs).42
The study performed by Kwon et al49 to evaluate the effect
of quercetin on Caco-2E intestinal cells documented that the
transport of fructose and glucose by GLUT2 was strongly
inhibited by quercetin. Blockage of tyrosine kinase is another
mechanism by which quercetin is reported to express effects
against diabetes.49 Furthermore, mitogen-activated protein
kinase pathway modulation is also a reported mechanism by
which quercetin performs action against hyperglycemia and
associated consequences.41
3.2. Myricetin
Myricetin, chemically known as 3,5,7,3′,4′,5′-
hexahydroxyﬂavone (Fig. 1), belongs to the ﬂavonol group
of polyphenols. An array of health-promoting effects of
myricetin has been demonstrated.50,51 Apart from myricetin’s
antioxidative, antiviral, and anticarcinogenic activities, con-
sumption of myricetin and reduced risk of diabetes have been
reported in many studies.51,52
122 Integr Med Res ( 2 0 1 4 ) 119–125
erceFig. 1 – Chemical structures of (A) qu
Myricetin is used as a traditional medicine in northern
Brazil to control hyperglycemia.52 Studies performed on dia-
betic rats revealed that myricetin prevents the condition of
hyperglycemia through different mechanisms. Myricetin has
the ability to promote glucose uptake in soleus muscles and
the liver, and enhance hepatic glycogen synthase activity and
thus glycogen synthesis in thehepatocytes of diabetic rats.53,54
It has been observed that myricetin may also elicit antidi-
abetic effects via the amelioration of insulin resistance.
Because insulin resistance is the most common etiology
of diabetes, improving insulin sensitivity followed by ame-
lioration of insulin resistance seems to be crucial for the
management of diabetes.55 A study performed by Liu et al55
showed that repeated intravenous injection of myricetin for
14 days increased the whole-body insulin sensitivity and
decreased the higher degree of insulin resistance in fructose
chow-fed rats.54 Recently, Ding et al52 reported thatmyricetin-
attenuated hyperinsulinemia induced insulin resistance in
skeletal muscle cells by increasing AMP-activated protein
kinase activity in C2C12 myotubes.52
During a drug screening study among 30 bioﬂavonoids on
glucose uptake under normal and insulin-stimulated con-
ditions in C2C12 myotubes, it was found that myricetin
was the only compound that stimulated insulin-mediated
lipogenesis.52 The insulin-mimicking effect of myricetin has
also been reported on glucose transport in adipocytes of rats
with noninsulin-dependent diabetes.53
Myricetin is reported to have a protective effect on
many oxidative stress-induced cellular abnormalities during
diabetes.51,56 There is strong evidence that myricetin could
effectively remove ROS owing to a large number of active
hydroxyl groups in its structure.51 A study performed on dia-
betic humanvolunteers of both sexeswith ameanageof 58±7
years, showed that myricetin at micromolar concentrations
signiﬁcantly protected the peroxidation of erythrocyte mem-
brane lipids and oxidation of proteins, which was increased
during oxidative stress.56 Myricetin has also been reported totin, (B) myricetin, and (C) resveratrol.
inhibit AGEs generation in diabetics.5 In addition, the antihy-
perlipidemic and inhibition of human pancreatic -amylase
is another effect through which myricetin may elicit a strong
antidiabetic effect.55
3.3. Resveratrol
Resveratrol (3,4′,5-trihydroxystilbene), which is a phytoalexin,
belongs to the stilbene class of polyphenolic compounds
(Fig. 1).57 Fresh grape skin contains about 50–100g of resver-
atrol per gram wet weight; its concentration is especially high
in red wine, which is made from grapes.58 Despite being dis-
covered in 1940, resveratrol was not a popular polyphenol in
laboratory studies until the 1990s. In 1992, Renaud and de
Lorgeril59 ﬁrst postulated that resveratrol present in the red
wine might play a major role in the prevention of cardiovas-
cular diseases among those who consume red wine regularly.
Later experimental evidence proved that resveratrol possesses
strong antioxidative, anti-inﬂammatory, cardioprotective, and
neuroprotective effects.60,61
Studies performed on a number of laboratory models and
on human volunteers have shown that resveratrol can elicit a
strong antidiabetic effect.62,63 In 2006, Orhan et al64 reported
that the extract of Vitis vinifera leaves, in which resveratrol is
present in considerable amounts, exhibited signiﬁcant anti-
hyperglycemic and antioxidant activity equipotent with the
reference hypoglycemic agent, tolbutamide. Another study
performed by Fujii et al65 in the same year documented
that polyphenolic compounds including resveratrol obtained
from grape seeds, showed protection against high glucose-
induced oxidative stress generally observed under diabetic
conditions. Resveratrol has also been shown to provide pro-
tection against diabetic nephropathy (Fig. 2).66 Treatment of
diabetic rats with resveratrol demonstrated the ameliora-
tion of renal dysfunction and oxidative stress.66 Impaired
cellular homeostasis is a common condition in diabetes,
responsible for the development of many associated cel-
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Fig. 2 – Schematic representation of the factors and mechanisms involved in the development of complications in diabetes
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ular as well as organ dysfunctions. Resveratrol has been
eported to restore cellular homeostasis signiﬁcantly via the
ctivation of the plasma membrane redox system, which
perates in the cell as a compensatory mechanism to main-
ain the redox state.67,68 The administration of resveratrol
o diabetic rats resulted in diminished levels of glycosylated
emoglobin.69
It has been proposed that the antihyperglycemic effect
f resveratrol observed in diabetic animals is attributable to
he stimulatory action of resveratrol on intracellular glucose
ransport. The presence of resveratrol caused increased glu-
ose uptake by different cells isolated from diabetic rats.70
he study on diabetic rats showed increased expression of the
nsulin-dependent glucose transporter (GLUT4) after resver-
trol ingestion.70,71 Resveratrol has also been reported to
odulate the activity of sirtuin-1, which improves whole-
ody glucose homeostasis and insulin sensitivity in diabetic
ats.70he prevention of diabetic pathologies.
4. Conclusion
Diabetes mellitus can compromise life quality and expectancy
in many ways. Molecular mechanisms involved in the degen-
erative consequences of hyperglycemia are mediated by
oxidative stress. Studies performed on model systems as well
as human trails provide evidence that quercetin, myricetin,
and resveratrol possess a strong ability to ameliorate biologi-
cal events responsible for hyperglycemia. These polyphenols
thus provide an alternative to conventional medicines toward
prevention and management of diabetes and related compli-
cations either alone or in combination with other therapies.Conﬂicts of interest
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